Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines

Among the well-established alterations contributing to prostate cancer (PCa) pathogenesis, epigenetics is an important player in its development and aggressive disease state. Moreover, since no curative therapies are available for advanced stage disease, there is an urgent need for novel therapeutic...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Mariana Brütt Pacheco, Vânia Camilo, Nair Lopes, Filipa Moreira-Silva, Margareta P. Correia, Rui Henrique, Carmen Jerónimo
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2021-07-01
Edice:	Pharmaceuticals
Témata:	castration-resistant prostate cancer epigenetics HDAC inhibitor DNMT inhibitor hydralazine panobinostat
On-line přístup:	https://www.mdpi.com/1424-8247/14/7/670
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!